V Molinie

Summary

Country: France

Publications

  1. doi [Extemporaneous examination in lung pathology: the pathologist's view]
    V Molinie
    Service d Anatomie Pathologique, Hopital Saint Joseph, 185, rue Raymond Losserand, 75014 Paris, France
    Rev Mal Respir 29:836-43. 2012
  2. pmc Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma
    Min Han Tan
    Laboratory of Cancer Genetics, Van Andel Research Institute, 333 Bostwick Avenue NE, Grand Rapids, MI 49503, USA
    BMC Cancer 10:196. 2010
  3. doi [Molecular biology and prostate cancer: evolution or revolution?]
    Vincent Molinie
    Service de Pathologie, Groupe Hospitalier Paris Saint Joseph, 185, rue Raymond Losserand, 75014 Paris, France
    Ann Pathol 28:354-62. 2008
  4. doi [Evaluation of p63 and p504s markers for the diagnosis of prostate cancer]
    Vincent Molinie
    Service de Pathologie, groupe hospitalier Saint Joseph, 185, rue Raymond Losserand, 75014 Paris, France
    Ann Pathol 28:417-23. 2008
  5. doi [Histological modifications observed in prostate after preserving treatments for prostate cancer and their impact on Gleason score interpretation]
    Vincent Molinie
    Service de Pathologie, Groupe Hospitalier Paris Saint Joseph, 185, rue Raymond Losserand, 75014 Paris Cedex, France
    Ann Pathol 28:363-73. 2008
  6. doi [Gleason's score: update in 2008]
    Vincent Molinie
    Service de Pathologie, Groupe Hospitalier Paris Saint Joseph, 185, rue Raymond Losserand, 75014 Paris Cedex, France
    Ann Pathol 28:350-3. 2008
  7. doi [The pathologist's perspective on the PCPT trial]
    V Molinie
    Service de Pathologie, Hopital Saint Joseph, 185 rue Raymond Losserand, Paris, France
    Prog Urol 18:S47-52. 2008
  8. ncbi [Contribution of pathological anatomy before and after total prostatectomy]
    V Molinie
    Service de Pathologie, Hopital Saint Joseph, 185, rue Raymond Losserand, 75674 Paris Cedex 14, France
    Ann Urol (Paris) 41:S51-8. 2007
  9. doi [Prostate biopsies: how many samples and how many containers? Cost effectiveness]
    Vincent Molinie
    Service de Pathologie, Groupe Hospitalier Paris Saint Joseph, 185, rue Raymond Losserand, 75014 Paris Cedex, France
    Ann Pathol 28:424-8. 2008
  10. doi [Androgen suppression for the treatment of prostate cancer in the elderly]
    P Mongiat-Artus
    Service d Urologie, Hopital Saint Louis, Paris, France
    Prog Urol 19:S151-5. 2009

Collaborators

Detail Information

Publications20

  1. doi [Extemporaneous examination in lung pathology: the pathologist's view]
    V Molinie
    Service d Anatomie Pathologique, Hopital Saint Joseph, 185, rue Raymond Losserand, 75014 Paris, France
    Rev Mal Respir 29:836-43. 2012
    ..After a presentation of the indications and practical modalities of extemporaneous examination, we will underline its limitations and insist on difficult situations for the pathologist and inadequate indications...
  2. pmc Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma
    Min Han Tan
    Laboratory of Cancer Genetics, Van Andel Research Institute, 333 Bostwick Avenue NE, Grand Rapids, MI 49503, USA
    BMC Cancer 10:196. 2010
    ..Previous studies have been relatively limited in terms of examining the differences between oncocytoma and chromophobe RCC...
  3. doi [Molecular biology and prostate cancer: evolution or revolution?]
    Vincent Molinie
    Service de Pathologie, Groupe Hospitalier Paris Saint Joseph, 185, rue Raymond Losserand, 75014 Paris, France
    Ann Pathol 28:354-62. 2008
    ..This discovery should pave the way towards future targeted therapies...
  4. doi [Evaluation of p63 and p504s markers for the diagnosis of prostate cancer]
    Vincent Molinie
    Service de Pathologie, groupe hospitalier Saint Joseph, 185, rue Raymond Losserand, 75014 Paris, France
    Ann Pathol 28:417-23. 2008
    ..Overall, from the 39/56 structures tested, the value of the test was positive in 85%. The best results were obtained after antigenic restoration with TRIS-EDTA pH 9, p504s (13H4, 1/200) and p63 (A4A, 1/100)...
  5. doi [Histological modifications observed in prostate after preserving treatments for prostate cancer and their impact on Gleason score interpretation]
    Vincent Molinie
    Service de Pathologie, Groupe Hospitalier Paris Saint Joseph, 185, rue Raymond Losserand, 75014 Paris Cedex, France
    Ann Pathol 28:363-73. 2008
    ....
  6. doi [Gleason's score: update in 2008]
    Vincent Molinie
    Service de Pathologie, Groupe Hospitalier Paris Saint Joseph, 185, rue Raymond Losserand, 75014 Paris Cedex, France
    Ann Pathol 28:350-3. 2008
    ..We present here the principal modifications of this score proposed in 2005 by the International Society of Uropathology...
  7. doi [The pathologist's perspective on the PCPT trial]
    V Molinie
    Service de Pathologie, Hopital Saint Joseph, 185 rue Raymond Losserand, Paris, France
    Prog Urol 18:S47-52. 2008
    ..If a prostate cancer with a Gleason score > or = 7 is diagnosed in a treated patient, the pathologist will perform a double reading of the slides to confirm the score...
  8. ncbi [Contribution of pathological anatomy before and after total prostatectomy]
    V Molinie
    Service de Pathologie, Hopital Saint Joseph, 185, rue Raymond Losserand, 75674 Paris Cedex 14, France
    Ann Urol (Paris) 41:S51-8. 2007
    ..After the radical prostatectomy, the pathologist has to analyze the surgical specimen. Two main features have to be reported including the tumor stage and the Gleason score...
  9. doi [Prostate biopsies: how many samples and how many containers? Cost effectiveness]
    Vincent Molinie
    Service de Pathologie, Groupe Hospitalier Paris Saint Joseph, 185, rue Raymond Losserand, 75014 Paris Cedex, France
    Ann Pathol 28:424-8. 2008
    ..A significant difference was observed only for the blocks containing six biopsies (p=0.02). Inclusion of one to three cores from each sextant, did not lead to a loss of information or loss of chances for the patient...
  10. doi [Androgen suppression for the treatment of prostate cancer in the elderly]
    P Mongiat-Artus
    Service d Urologie, Hopital Saint Louis, Paris, France
    Prog Urol 19:S151-5. 2009
    ..Intermittent androgen suppression should be considered with caution. Close follow up will focus on the diagnosis of adverse effects of androgen suppression...
  11. ncbi [New markers in prostate biopsies]
    V Molinie
    Department of Pathology, Hopital Saint Joseph, Paris, France
    Actas Urol Esp 31:1009-24. 2007
    ....
  12. ncbi Diagnostic utility of a p63/alpha-methyl coenzyme A racemase (p504s) cocktail in ambiguous lesions of the prostate upon needle biopsy
    Vincent Molinie
    Department of Pathology, Hopital Saint Joseph, Paris, France
    BJU Int 97:1109-15. 2006
    ..To investigate the potential utility of a new combined immunostaining technique for diagnosing prostate cancer from histological analysis of needle biopsy specimens...
  13. ncbi [Is tumour grade applicable to finasteride-treated prostate cancer?]
    Vincent Molinie
    Fondation Hopital Saint Joseph, Paris, France
    Prog Urol 15:387-91. 2005
    ....
  14. doi [Results of total prostatectomy in the elderly patient]
    M Peyromaure
    Hopital Cochin, 27, rue du Faubourg St Jaques, 75014 Paris, France
    Prog Urol 19:S147-50. 2009
    ..There are no studies comparing the various curative treatments of Prostate cancer (RP, radiation therapy, brachytherapy, active surveillance) in the elderly population...
  15. ncbi Diagnostic utility of a p63/alpha-methyl-CoA-racemase (p504s) cocktail in atypical foci in the prostate
    Vincent Molinie
    Service de Pathologie, Hopital Foch, Suresnes, France
    Mod Pathol 17:1180-90. 2004
    ....
  16. ncbi [Value of new prostate cancer markers: alpha methylacyl CoA racemase (P504S) and p63]
    Vincent Molinie
    Service d Anatomie et Cytologie Pathologiques, Hopital Saint Joseph, Paris, France
    Prog Urol 15:611-5. 2005
    ....
  17. ncbi Parafibromin as a new immunohistochemistry staining to improve pathologic diagnosis of renal oncocytoma: Analysis of 225 renal tumors
    L Albiges
    Medical Oncology Department, Institut Gustave Roussy, Villejuif, France Institut Curie, Paris, France Hopital Henry Mondor, Creteil, France Hôpital Foch, Suresnes, France Hôpital Tenon, Paris, France Hôpital Cochin, Paris, France Van Andel Research Institute, Grand Rapids, MI Hospital Saint Joseph, Paris, France
    J Clin Oncol 29:408. 2011
    ..This work aims at evaluating the diagnostic value of Parafibromin (Pf) immuno staining on a large number of renal tumor samples...
  18. doi [The role of the pathologist in the diagnosis of metastases from urological malignancies]
    V Molinie
    Service de Pathologie, Hopital Saint Joseph, Paris, France
    Prog Urol 18:S178-95. 2008
    ..In this review we approach the various morphological criteria and the interest of the various antibodies to confirm the urologic origin of a metastasis...
  19. ncbi [Pathological interpretation of radical prostatectomy]
    V Molinie
    Service d Anatomie et de Cytologie Pathologiques, Hopital Saint Joseph, 185, rue Raymond Losserand, 75674 Paris cedex, France
    Ann Urol (Paris) 40:S32-4. 2006
    ..The vast majority of departments of pathology in French institutions are used to study radical prostatectomy specimens obtained from the entire prostate gland...
  20. ncbi Alpha-methyl CoA racemase expression in renal cell carcinomas
    Vincent Molinie
    Department of Pathology, Hopital Saint Joseph, 75014 Paris Cedex, France
    Hum Pathol 37:698-703. 2006
    ....